drug · antibody
patient view →ranibizumab biosimilar
Phase 3updated 2mo agoby Lupin Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 9 approved and 26 investigational indications.
indications
indications
Diabetic Macular Edema
targets
Vascular endothelial growth factor A, long form
all catalysts(5)
filing · 5
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that